These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9754654)

  • 21. Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens.
    Kirkin AF; thor Straten P; Zeuthen J
    Cancer Immunol Immunother; 1996 May; 42(4):203-12. PubMed ID: 8665567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response.
    Pfirschke C; Gebhardt C; Zörnig I; Pritsch M; Eichmüller SB; Jäger D; Enk A; Beckhove P
    Cancer Immunol Immunother; 2015 Nov; 64(11):1369-81. PubMed ID: 26160687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients.
    Jacobs JF; Aarntzen EH; Sibelt LA; Blokx WA; Boullart AC; Gerritsen MJ; Hoogerbrugge PM; Figdor CG; Adema GJ; Punt CJ; de Vries IJ
    Cancer Immunol Immunother; 2009 Jan; 58(1):145-51. PubMed ID: 18392619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD29 identifies IFN-γ-producing human CD8
    Nicolet BP; Guislain A; van Alphen FPJ; Gomez-Eerland R; Schumacher TNM; van den Biggelaar M; Wolkers MC
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6686-6696. PubMed ID: 32161126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of CD8
    O'Melia MJ; Rohner NA; Manspeaker MP; Francis DM; Kissick HT; Thomas SN
    Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33310857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer immune reaction and lymph node sinus macrophages: a review from human and animal studies.
    Fujiwara Y; Yano H; Pan C; Shiota T; Komohara Y
    J Clin Exp Hematop; 2024; 64(2):71-78. PubMed ID: 38925976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of direct adrenergic innervation after peripheral nerve injury causes lymph node expansion through IFN-γ.
    Chen CS; Weber J; Holtkamp SJ; Ince LM; de Juan A; Wang C; Lutes L; Barnoud C; Kizil B; Hergenhan SM; Salvermoser J; Lasch M; Deindl E; Schraml B; Baumjohann D; Scheiermann C
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34086056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A listing of human tumor antigens recognized by T cells.
    Renkvist N; Castelli C; Robbins PF; Parmiani G
    Cancer Immunol Immunother; 2001 Mar; 50(1):3-15. PubMed ID: 11315507
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxidized Melanoma Antigens Promote Activation and Proliferation of Cytotoxic T-Cell Subpopulations.
    Clemen R; Miebach L; Singer D; Freund E; von Woedtke T; Weltmann KD; Bekeschus S
    Adv Sci (Weinh); 2024 Sep; 11(33):e2404131. PubMed ID: 38958560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-specific and cross-reactive T cells in protection and disease.
    Jiang N; Malone M; Chizari S
    Immunol Rev; 2023 Jul; 316(1):120-135. PubMed ID: 37209375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of T cells specific for cryptic epitopes in melanoma patients.
    Andersen RS; Andersen SR; Hjortsø MD; Lyngaa R; Idorn M; Køllgård TM; Met O; Thor Straten P; Hadrup SR
    Oncoimmunology; 2013 Jul; 2(7):e25374. PubMed ID: 24073381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
    Larrieu P; Renaud V; Godet Y; Jotereau F; Fonteneau JF
    Cancer Immunol Immunother; 2008 May; 57(5):745-52. PubMed ID: 18097665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting.
    Labarrière N; Gervois N; Bonnin A; Bouquié R; Jotereau F; Lang F
    Cancer Immunol Immunother; 2008 Feb; 57(2):185-95. PubMed ID: 17646986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes.
    Larrieu P; Ouisse LH; Guilloux Y; Jotereau F; Fonteneau JF
    Cancer Immunol Immunother; 2007 Oct; 56(10):1565-75. PubMed ID: 17318652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
    Harlin H; Kuna TV; Peterson AC; Meng Y; Gajewski TF
    Cancer Immunol Immunother; 2006 Oct; 55(10):1185-97. PubMed ID: 16468035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects.
    Lesimple T; Moisan A; Carsin A; Ollivier I; Mousseau M; Meunier B; Leberre C; Collet B; Quillien V; Drenou B; Lefeuvre-Plesse C; Chevrant-Breton J; Toujas L
    Cancer Immunol Immunother; 2003 Jul; 52(7):438-44. PubMed ID: 12690521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
    Labarriere N; Pandolfino MC; Raingeard D; Le Guiner S; Diez E; Le Dréan E; Dreno B; Jotereau F
    Int J Cancer; 1998 Oct; 78(2):209-15. PubMed ID: 9754654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
    Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
    Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.